Liver/Biliary Disorders News

Roux-en-Y gastric bypass and sleeve gastrectomy are equally effective at reducing hepatic steatosis, with an almost complete clearance of liver fat 1 year after the surgical procedures, according to data from a single-center study.

In this exclusive video, Andrew Allegretti, MD, MSc, discussed a post hoc analysis assessing serum creatinine in patients treated with terlipressin for hepatorenal syndrome-acute kidney injury.

In a video exclusive, Gideon Hirschfield, PhD, FRCP, of the University of Toronto, reported the potential of obeticholic acid for improving transplant-free survival among patients with primary biliary cholangitis.

Rifaximin plus or minus lactulose compared with lactulose alone correlated with a decrease in ED health care utilization in patients with hepatic encephalopathy, according to a presentation at the ACG Annual Scientific Meeting.

Using a cirrhosis-centric model, researchers found a high prevalence for anxiety in patients with cirrhosis, according to a presentation at The Liver Meeting Digital Experience.

Pegbelfermin was safe and effective in improving markers of steatosis, fibrosis and inflammation among patients with nonalcoholic steatohepatitis with stage 3 fibrosis, according to a presentation at The Liver Meeting Digital Experience.

Increased awareness is needed to mitigate burden fatty liver disease and modifiable risk factors among adolescents and young adults, according to research presented at The Liver Meeting Digital Experience.

Improvements in intrahepatic and circulatory inflammation markers were observed after fecal microbiota transplantation in patients with severe alcohol associated hepatitis, according to a presenter at The Liver Meeting Digital Experience.

To streamline and validate diagnosis of and clinical trials in non-alcoholic steatohepatitis, one group is on a mission to determine the best non-invasive tests for all physicians to use, according to a presentation.

Vonafexor induced a strong reduction in liver fat content and improvements in biochemical and imaging markers of liver inflammation and kidney function, according to a presenter at The Liver Meeting Digital Experience.